Choom Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Choom Holdings's earnings have been declining at an average annual rate of -38.1%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 78.6% per year.
Belangrijke informatie
-38.1%
Groei van de winst
-17.6%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 23.1% |
| Inkomstengroei | 78.6% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -84.1% |
| Laatste winstupdate | 31 Dec 2021 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Choom Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 21 | 19 | -16 | 9 | 0 |
| 30 Sep 21 | 21 | -13 | 9 | 0 |
| 30 Jun 21 | 22 | -20 | 9 | 0 |
| 31 Mar 21 | 21 | -15 | 9 | 0 |
| 31 Dec 20 | 18 | -15 | 9 | 0 |
| 30 Sep 20 | 13 | -19 | 10 | 0 |
| 30 Jun 20 | 7 | -20 | 10 | 0 |
| 31 Mar 20 | 4 | -16 | 10 | 0 |
| 31 Dec 19 | 2 | -16 | 11 | 0 |
| 30 Sep 19 | 0 | -12 | 12 | 0 |
| 30 Jun 19 | 0 | -11 | 12 | 0 |
| 31 Mar 19 | 0 | -13 | 12 | 0 |
| 31 Dec 18 | 0 | -10 | 10 | 0 |
| 30 Sep 18 | 0 | -8 | 8 | 0 |
| 30 Jun 18 | 0 | -6 | 5 | 0 |
| 31 Mar 18 | 0 | -3 | 2 | 0 |
| 31 Dec 17 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -1 | 0 | 0 |
| 30 Jun 17 | 0 | -1 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | -1 | 0 | 0 |
| 30 Sep 16 | 0 | -1 | 0 | 0 |
| 30 Jun 16 | 0 | -1 | 0 | 0 |
| 31 Mar 16 | 0 | -1 | 0 | 0 |
| 31 Dec 15 | 0 | -1 | 0 | 0 |
Kwaliteitswinsten: CHOO is currently unprofitable.
Groeiende winstmarge: CHOO is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CHOO is unprofitable, and losses have increased over the past 5 years at a rate of 38.1% per year.
Versnelling van de groei: Unable to compare CHOO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: CHOO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).
Rendement op eigen vermogen
Hoge ROE: CHOO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.